Health

Rapid Medical Announces FDA Approval of Novel Temporary Aneurysm Embolization Assist Device

YOKNEAM, Israel, May 7, 2019 /PRNewswire/ -- Rapid Medical , a company focused on the development of next generation neurovascular devices, today announced that its Comaneci device received FDA clearance as a Temporary Coil Embolization Assist Device. The Comaneci ...

2019-05-07 09:00 1461

Evolve BioSystems Makes Evivo Available in Hong Kong, Singapore

Launch of Activated Form of Critical Bacteria B. Infantis in Asia Fulfills Li Ka Shing Foundation's Vision, Caps First Quarter of Major Activity in the Continent DAVIS, California, May 7, 2019 /PRNewswire/ -- Evolve BioSystems, makers of  Evivo® baby probiotic, today announced that its flagship c...

2019-05-07 05:00 2049

US and Canada Clinical Laboratories to Strike the 100 Billion Market Cap

Labs must demonstrate agility and adaptability in preparing for reimbursement headwinds while taking advantage of growth opportunities, finds Frost & Sullivan SANTA CLARA, California, May 7, 2019 /PRNewswire/ -- The growing trend of decentralization has expanded the scope of testing beyond the tr...

2019-05-07 01:18 1027

Inovio Receives European Medicines Agency Certification For Quality and Non-Clinical Data for Its Phase 3 Product, VGX-3100

PLYMOUTH MEETING, Pennsylvania, May 6, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced that its lead Phase 3 product candidate, VGX-3100, has been granted an Advanced Therapy Medicinal Product Certificate for quality and non-clinical data. The procedure of certifi...

2019-05-06 21:00 1965

Bardy Diagnostics Earns Acclaim from Frost & Sullivan for Its Groundbreaking Carnation Ambulatory Monitor™ Patch for Arrhythmia Monitoring

CAM™'s unique P-wave-centric ECG monitor offers unmatched signal clarity and superior arrhythmia detection SANTA CLARA, California, May 6, 2019 /PRNewswire/ -- Based on its recent analysis of the North American remote cardiac monitoring market, Frost & Sullivan recognizesBardy Diagnostics, Inc. ...

2019-05-06 20:00 1274

Frost & Sullivan Publishes Annual Update on Cellect

TEL AVIV, Israel, May 6, 2019 /PRNewswire/ -- The TASE analysis project was launched in 2016 in order to raise investor awareness to TASE listed technology and life-science companies and the markets in which these companies operate, thus creating appropriate pricing and increasing the exposure of...

2019-05-06 18:11 859

Frost & Sullivan Publishes Annual Update on Brainsway

TEL AVIV, Israel, May 6, 2019 /PRNewswire/ -- The TASE analysis project was launched in 2016 in order to raise investor awareness to TASE listed technology and life-science companies and the markets in which these companies operate, thus creating appropriate pricing and increasing the exposure of...

2019-05-06 17:57 859

Connect Biopharma Reports Positive Phase 1 Data and Announces Initiation of Phase 1b Study in Patients with Atopic Dermatitis for Novel IL-4Rα Antibody CBP-201

TAICANG, China, May 6, 2019 /PRNewswire/ -- Connect Biopharma today announced that it has successfully completed a phase 1 single ascending dose (SAD) study of its novel IL-4Rα antibody, CBP-201. The randomized, double-blind, placebo-controlled study, conducted inMelbourne, Australia, evaluated t...

2019-05-06 17:00 883

Scientific Advisory Board Announced for DELopen to Guide the Open Access DNA Encoded Library Interchange

SHANGHAI and BOSTON, May 6, 2019 /PRNewswire/ -- DELopen, a new platform dedicated to the hit generation of drug discovery of DNA Encoded Library (DEL) Technology, has announced the formation of its Scientific Advisory Board. The board, chaired by Dr. Richard Lerner, Institute Professor of Scripp...

2019-05-06 13:38 1432

Harbour BioMed and Chia Tai Tianqing Pharmaceutical Group Ltd. Announce Strategic Alliance to Discover, Develop and Commercialize Innovative Biologics

CAMBRIDGE, Mass., ROTTERDAM, Netherlands, and SHANGHAI, May 6, 2019 /PRNewswire/ -- Harbour BioMed and Chia Tai Tianqing Pharmaceutical Group Ltd. (CTTQ) today announced they are entering into a strategic alliance to discover, develop and commercialize next-generation biologics for multiple thera...

2019-05-06 10:49 1772

WuXi AppTec Acquires Pharmapace to Enhance Biometrics Services for Clinical Development

SHANGHAI and SAN DIEGO, May 5, 2019 /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company, today announced that it has acquired Pharmapace, Inc., a US-based clinical research services company with expertise of provid...

2019-05-06 07:50 2563

Darren Birkelbach Appointed President Of American International Chemical, LLC

NORWALK, Connecticut, May 4, 2019 /PRNewswire/ -- Charles Hinnant, CEO of LBB Specialties LLC, announced that effectiveMay 15, Darren J. Birkelbach will become President of American International Chemical, LLC ("AIC"), a subsidiary of LBB Specialties. Mr. Birkelbach joins AIC after a successful ...

2019-05-04 00:30 1732
1 ... 558559560561562